Taiwan
· Delayed Price · Currency is TWD WeLeader Biomedical Statistics
Total Valuation
TPEX:7713 has a market cap or net worth of TWD 3.17 billion. The enterprise value is 3.77 billion.
| Market Cap | 3.17B |
| Enterprise Value | 3.77B |
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:7713 has 41.58 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 41.58M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +51.57% |
| Owned by Insiders (%) | 21.61% |
| Owned by Institutions (%) | 2.52% |
| Float | 5.59M |
Valuation Ratios
The trailing PE ratio is 18.85.
| PE Ratio | 18.85 |
| Forward PE | n/a |
| PS Ratio | 2.95 |
| PB Ratio | 3.79 |
| P/TBV Ratio | 4.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.58, with an EV/FCF ratio of -80.31.
| EV / Earnings | 25.03 |
| EV / Sales | 3.95 |
| EV / EBITDA | 12.58 |
| EV / EBIT | 19.46 |
| EV / FCF | -80.31 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.92 |
| Debt / EBITDA | 2.14 |
| Debt / FCF | -13.66 |
| Interest Coverage | 44.29 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 4.75M |
| Profits Per Employee | 749,560 |
| Employee Count | 201 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.39% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +8.39% |
| 50-Day Moving Average | 79.11 |
| 200-Day Moving Average | 73.40 |
| Relative Strength Index (RSI) | 45.82 |
| Average Volume (20 Days) | 15,937 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:7713 had revenue of TWD 954.87 million and earned 150.66 million in profits. Earnings per share was 4.04.
| Revenue | 954.87M |
| Gross Profit | 291.61M |
| Operating Income | 193.72M |
| Pretax Income | 191.67M |
| Net Income | 150.66M |
| EBITDA | 224.65M |
| EBIT | 193.72M |
| Earnings Per Share (EPS) | 4.04 |
Balance Sheet
The company has 113.50 million in cash and 641.46 million in debt, giving a net cash position of -527.97 million or -12.70 per share.
| Cash & Cash Equivalents | 113.50M |
| Total Debt | 641.46M |
| Net Cash | -527.97M |
| Net Cash Per Share | -12.70 |
| Equity (Book Value) | 695.31M |
| Book Value Per Share | 20.10 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 235.40 million and capital expenditures -282.35 million, giving a free cash flow of -46.95 million.
| Operating Cash Flow | 235.40M |
| Capital Expenditures | -282.35M |
| Free Cash Flow | -46.95M |
| FCF Per Share | -1.13 |
Margins
Gross margin is 30.54%, with operating and profit margins of 20.29% and 15.78%.
| Gross Margin | 30.54% |
| Operating Margin | 20.29% |
| Pretax Margin | 20.07% |
| Profit Margin | 15.78% |
| EBITDA Margin | 23.53% |
| EBIT Margin | 20.29% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.30, which amounts to a dividend yield of 3.02%.
| Dividend Per Share | 2.30 |
| Dividend Yield | 3.02% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 22.99% |
| Buyback Yield | -32.55% |
| Shareholder Yield | -29.53% |
| Earnings Yield | 4.76% |
| FCF Yield | -1.48% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |